Aspects of patient management initiating Allergy Immunotherapy (AIT) for seasonal allergies in COVID-19 times

Date/Time: Tuesday 29th September 2020,11:00 - 11:45 CEST


As social distancing restrictions begin to ease around the world and a growing number of countries begin to reopen, we explore patient management and the successful initiation of Allergy Immunotherapy (AIT) against the backdrop of COVID-19. Three leading allergy experts from around the world will share their thoughts and considerations for best practice initiation and supporting patient adherence during the ongoing pandemic and enter a new cycle of seasonal allergy.


Under assessment for CME accreditation.
This webinar is intended for Healthcare Professionals only.



Expert panel

Professor Stephen Durham

Stephen R Durham is Head of Section for Allergy and Clinical Immunology at NHLI, Imperial College and Professor of Allergy and Respiratory Medicine at Royal Brompton Hospital London. He is current President of the British Society for Allergy and Clinical Immunology and a member of the Immune Tolerance Network Steering Committee of the National Institutes of Health. He is former Chair of the Research Committee of the World Allergy Organisation and council member of Collegium Internationale Allergologicum.

Professor Martin Wagenmann

Martin Wagenmann is Head of the Rhinology, Allergology and Endoscopic Skull Base Surgery department at the Dusseldorf University Hospital. He also heads the research laboratory of the ENT clinic at Heinrich Heine University in Dusseldorf. Since 1990 he has been conducting clinical and experimental studies, coordinating and writing national as well as international guidelines while collaborating in several societies, including the German Society for Allergy and Clinical Immunology (DGAKI) as well as the European Academy of Allergy and Clinical Immunology (EAACI).

Professor Zhang Luo

Prof. Zhang Luo, MD, PHD, President of Beijing Tongren Hospital. As the Changjiang distinguished professor and the winner of The National Science Fund for Distinguished Young Scholars, he devoted himself in the field of chronic nasal diseases, such as chronic sinusitis, allergic rhinitis and inverted papilloma. He has published 518 papers as the first or corresponding author, including 235 in English journals, and won the National Excellent Scientific and Technological Workers Award and China Youth Science and Technology Award.



Dr Phillip Hammond

Dr Phil Hammond is a doctor, journalist, broadcaster, campaigner and comedian. He has been Private Eyes medical correspondent for over 20 years and has appeared on Have I Got News for You, The News Quiz, The Now Show, The One Show and Countdown.